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Time trendsIn the last decade, physiologically based pharmacokinetic (PBPK) models have increasingly been developed to
explain the kinetics of environmental pollutants in wildlife. For marine mammals speciﬁcally, these models
provide a new, non-destructive tool that enables the integration of biomonitoring activities and in vitro
studies. The goals of the present study were ﬁrstly to develop PBPKmodels for several environmental relevant
PCB congeners in harbor porpoises (Phocoena phocoena), a species that is sensitive to pollution because of its
limited metabolic capacity for pollutant transformation. These models were tested using tissue data of
porpoises from the Black Sea. Secondly, the predictive power of themodels was investigated for time trends in
the PCB concentrations in North Sea harbor porpoises between 1990 and 2008. Thirdly, attempts were made
to assess metabolic capacities of harbor porpoises for the investigated PCBs. In general, results show that
parameter values from other species (rodents, humans) are not always suitable in marine mammal models,
most probably due to differences in physiology and exposure. The PCB 149 levels decrease the fastest in male
harbor porpoises from the North Sea in a time period of 18 years, whereas the PCB 101 levels decrease the
slowest. According to themodels, metabolic breakdown of PCB 118 is probably of lesser importance compared
to other elimination pathways. For PCB 101 and 149 however, the presence of their metabolites can be
attributed to bioaccumulation of metabolites from the prey and to metabolic breakdown of the parent
compounds in the harbor porpoises.hysiology, Biochemistry and
erp, Groenenborgerlaan 171,
3 265 34 97.
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The global awareness of the major impact of anthropogenically
produced pollutants on the environment makes risk assessment in
wildlife a topic of great interest. Assessing toxicity in organisms
requires correlations between the concentration of a chemical in an
organism and the response induced by that speciﬁc pollutant (Walker
et al., 2006). Typically, this approach leads to some practical problems
for marine mammals. Marine mammals are long-lived mammals that
occupy the top positions in aquatic foodwebs around the world (Ross,
2000) and that can transfer considerable amounts of pollutants to
their offspring through lactation because of their lipid rich milk
(Debier et al., 2003). They have limited capacities for eliminating
pollutants and have experienced effects on several health endpoints
(e.g. Mos et al., 2007; Reijnders, 1986; Ross et al., 1996). Because of
this, marine mammals are sensitive to pollution and thereforerelevant study organisms (Ross, 2000). However, due to their
protected status, in vivo toxicological research or exposure experi-
ments in marine mammals are undesirable and prohibited. As a
consequence, due to the more advanced techniques and procedures,
risk assessment inmarinemammals occursmore andmore through in
vitro studies (e.g. Dufresne et al., 2010; Li et al., 2003; McKinney et al.,
2006), probably the only ethical possibility to investigate the effects of
pollution in these animals. However, such work focusesmainly on one
target tissue or type of cells. It thus fails to provide an integrative
picture and to understand the interactions between several tissues.
Computer models or in silico studies may be able to provide a
solution. The type of models used depends on the questions that need
to be addressed or on the availability of data required to develop the
models. Physiologically based pharmacokinetic (PBPK) models give
information about the absorption, elimination and distribution of a
pollutant in an organism by integrating physiology of the organism
and biochemistry of the speciﬁc pollutant (Clewell and Clewell, 2008;
Reddy et al., 2005). Traditionally, these models were used to describe
the kinetics of chemicals in rodents (Corley et al., 1990; Reitz et al.,
1988). Recently, the bioaccumulation of environmental pollutants,
such as polychlorinated biphenyls (PCBs) in wildlife and humans has
Table 1
Compound speciﬁc parameters for several PCBs. PCB congeners were selected based on
the groups from Wolkers et al. (1998). The original values of the parameters are given
between brackets for parameters that were ﬁtted to the data.
PCB 180 PCB 101 PCB 149 PCB 118 PCB 99 PCB 170
Groupa I II II IIIa IIIb IIIb
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2006; Redding et al., 2008; Sonne et al., 2009; Verner et al., 2008;
Weijs et al., 2010b).
Harbour porpoises (Phocoena phocoena) are small cetaceans living in
the Northern Hemisphere. They are apex predators, have long life spans
and are assumed to have limitedmetabolic capacities for thebreakdown
of pollutants compared to other marine mammals, such as harbor seals
(Weijs et al., 2009a, 2009b). During the last decade, populations of
harbor porpoises innorthernEuropeweremovingmore south, probably
following the ﬁsh migrations, towards the relatively smaller and more
land locked North Sea (SCANS II, 2006), thereby exposing themselves to
higher levels of pollutants that are present in that area due to run-off of
the highly industrialized surrounding countries. Together with their
potential limited metabolic capacities, there is a clear need for
information regarding the kinetics and effects of pollutants in their
bodies to ensure proper protection and viable populations worldwide.
Recently, models were developed for the lifetime distribution and
kinetics of PCB 153 in harbor porpoises which is the most persistent PCB
in marine mammals (Weijs et al., 2010b). However, PCB 153 is not the
only threat for theseanimals as it is onlyonecongener in thePCBmixtures
(Aroclor) which were commercially available and widely used before
their ban in the 1970s. The goals of the present studywere therefore, 1) to
develop PBPKmodels for PCBs other than PCB 153 in harbor porpoises, 2)
to investigate the temporal trendsofPCBsusing thesemodels, 3) togather
more information about the metabolic breakdown of some PCBs.
The PCBs other than PCB 153 were selected according to the
chlorine substitution pattern on the ortho, meta and para positions
(Wolkers et al., 1998) implying that they are all metabolized by
different subsystems of the cytochrome P450 enzyme complex.
Congeners PCB 180 (group I), PCB 101 (group II), PCB 118 (group
IIIa) and PCB 170 and PCB 99 (group IIIb) were chosen because of their
persistence in marine mammals. A model for PCB 149 (group II) was
developed as well because of its typically higher concentrations in
cetaceans compared to pinnipeds (Boon et al., 1997).log (Kfp)b 2.41682 1.91643 1.85712 2.23748 2.41682 2.41682
PFc 380.2 101.4 88.5 251.6 380.2 380.2
PLc 9.0 2.4 2.1 6.0 9.0 9.0
PKc 5.3 1.4 1.2 3.5 5.3 5.3
PBc 6.3 (15.2) 1.3 (4.0) 1.4 (3.5) 3.5 (10.0) 6.3 (15.2) 6.1 (15.2)
PRc 9.2 2.5 2.2 6.1 9.2 9.2
AE 1 (%)d 91 98 90 99 90 90
AE 2 (%)e 54 66 54 70 55 46
CFetusFf 53.6 87.1 99.3 113.1 61.0 18.0
CFetusLf 33.0 37.4 49.4 43.8 26.8 10.4
CFetusKf 32.9 48.6 58.2 52.1 36.0 ND
CFetusBf 8.5 11.7 13.6 13.7 8.2 ND
Half lifeg 521 (9.9) 6.1 (5.7) 80.00 (5.7) 9.6 334 (5.7) 21.0 (3.9)
Kfp — adipose tissue/plasma partition coefﬁcient, PF — adipose tissue/blood partition
coefﬁcient, PL — liver/blood partition coefﬁcient, PK — kidney/blood partition
coefﬁcient, PB — brain/blood partition coefﬁcient, PR — muscle/blood partition
coefﬁcient, AE — assimilation efﬁciency.
a Groups based on the chlorine substitution pattern on the ortho, meta and para
positions according to Wolkers et al. (1998).
b Adipose tissue to plasma partition coefﬁcients from Parham et al. (1997).
c Equations from Parham et al. (1997) were transformed to equations for bottlenoseMaterials and methods
PBPK models were constructed for six PCB congeners and were
based on our earlier published model for PCB 153 in male harbor
porpoises (Weijs et al., 2010b). Accordingly, all models consist of 5
compartments: liver, blubber, kidneys, brain and rest of the body
(Fig. 1), all connected through blood. For the ‘rest of the body’-
compartment, parameters and data of muscle tissue of harbor
porpoises were used. All tissues were considered to be ﬂow-limited
similar as in Weijs et al. (2010b) and for humans in Redding et al.
(2008). Exposure was assumed to be through ﬁsh and milk
consumption only. Dermal uptake was neglected because lipophilic
compounds do not dissolve readily in sea water. Moreover, Hickie et
al. (1999) found that dermal exposure only played a negligible role for
the bioaccumulation of PCBs in beluga whales. The uptake of PCBs
through the ﬁsh or milk diet was set to the liver as this compartmentKidney
Liver Blubber
Brain
Input (fish, milk)
Rest of the body
Elimination (e.g. metabolic biotransformation, feces)
Fig. 1. Conceptual representation of the PBPK models for selected PCBs in male harbor
porpoises.was the only tissue of the gastrointestinal tract represented in the
models. All models were coded using Berkeley Madonna (version
8.3.14) and are available on request to the corresponding author.
Parameters. All models were developed using parameters from the
literature or obtained through ﬁtting to the data if clearly indicated.
The same physiological parameters and equations of the male harbor
porpoises as in Weijs et al. (2010b) were used. Biochemical
parameters were adjusted according to the speciﬁc PCB (Table 1).
Blood/tissue partition coefﬁcients were calculated using the approach
from Parham et al. (1997) and the average lipid percentage of the
tissues which can be found in Weijs et al. (2010a). However, blood/
brain partition coefﬁcients (PB) calculated with this approach over-
estimated the levels of the PCBs in the brain of the Black Sea harbor
porpoises and were therefore ﬁtted to the data of the brain. Both
calculated and predicted PBs can be found in Table 1. Other
parameters that were ﬁtted (elimination half-lives and assimilation
efﬁciency for the milk or AE2; see Table 1) were chosen upon visual
inspection of the position and shape of the curves compared to the
real-life data from animals from the Black Sea. In general, the
following order in the ﬁtting process was followed: Elimination
half-lives were ﬁtted ﬁrst as this parameter affects the slope of the
curve in each compartment, AE2 was ﬁtted after that as it determined
only the concentrations in all compartments for animals b1 year and
PBs only had an impact on the curve of the brain compartment and
were therefore ﬁtted last. Overall, ﬁtting or estimating several
parameter values through modeling generally reduces the reliabilitydolphins (blood composition from Bossart et al. (2001)). For partition coefﬁcients of
tissues (liver, kidneys, brain) as given in Table 1, the average lipid content was used
(Weijs et al., 2010a). For the ‘rest of the body’-compartment, the average lipid content
of muscle was used (Weijs et al., 2010a).
d Assimilation efﬁciency for the ﬁsh diet or the percentage of PCB absorbed by the
juveniles and adults after ingestion of the ﬁsh prey. Values taken from Thomas et al.
(2005), average net absorption for all congeners measured was N89%, so for PCB 99, PCB
149 and PCB 170, an assimilation efﬁciency of 90% was assumed.
e Assimilation efﬁciency for the milk diet or the percentage of PCB absorbed by the
calves after milk ingestion. Values were ﬁtted to the Black Sea dataset.
f Results from own analyses (Weijs, unpublished data) and expressed in ng/g lipid
weight (lw). For modeling purposes, values of 0.01 ng/g lw were used for
concentrations below limit of detection (ND). Muscle tissue of the neonate/fetus was
not available, so a value of 0.01 ng/g lw was used in the models as well.
g Values between brackets are the original elimination half-lives used in the ﬁrst
modeling attempt. Other values are ﬁtted to the dataset for validation and are used in
all other models (models for goals 2 and 3) of this study.
138 L. Weijs et al. / Toxicology and Applied Pharmacology 256 (2011) 136–145of the model outcome as these parameters are more mathematically
justiﬁed than biologically inspired. Therefore, this procedure was kept
to a minimum and only employed in cases where there were no
parameters available in the literature or where the parameters (the
models) did not match the real-life data from the harbor porpoises.
Datasets. Physiological parameters were kept rather general so that the
models would be species-speciﬁc instead of population-speciﬁc. In that
way, it is assumed that the models can be used for all male harbor
porpoises. The models include also ﬁve compartments which allows to
use other data than only PCB levels in blubber. All this is reﬂected here
as there are several datasets used for the different applications:
Black Sea. This dataset was used to parameterize the PCB models
(goal 1), similar to the PCB 153 model in male harbor porpoises
(Weijs et al., 2010b). All animals (9 juveniles, 11 adults) were by-
caught (n=17) or found stranded (n=3) in 1998 in the Black Sea.
Carcasses were in good condition or only moderately composed and
none of the animals was severely emaciated. Levels in blubber, liver,
kidney, brain andmuscle are discussed inWeijs et al. (2010a). Levels
of one neonate/fetus (Table 1) were used as well together with the
levels of PCBs in milk of Black Sea harbor porpoises (Table S1).
North Sea. This dataset consists of blubber and liver PCB
concentrations. The blubber data were used to investigate the
predictability of the PBPK model for the PCBs in time (goal 2), the
liver data were used to better understand the importance of
metabolic breakdown of some PCB parent compounds (goal 3).
One part of the animals included in this dataset were found
stranded or were by-caught on the Belgian coast of the North Sea
in 1999–2004. The PCB results in blubber (n=20) were used for
goal 2 and can be found in Weijs et al. (2009a and b). The PCB,
methylsulfone-PCB (MeSO2-PCB) and hydroxylated PCB metabo-
lites (HO-PCB) levels in liver (n=10) were used for goal 3 and
were discussed in Covaci et al. (2002) (PCBs), in Chu et al. (2003)
(MeSO2-PCBs) and were from Weijs (unpublished data) (HO-
PCBs) (Table 2). The other part of the animals included in this
dataset (n=26)were found alive on the coasts of Belgium and TheTable 2
Hydroxylated (HO) and methylsulfone (MeSO2)-metabolites of the parent PCB
compounds in liver of harbor porpoises from the North Sea (n=10; expressed in
ng/g lw). Parent PCB compounds are discussed in Covaci et al. (2002), MeSO2-PCBs
in Chu et al. (2003), HO-PCBs from Weijs, unpublished data.
PCB 180 PCB 101 PCB 149 PCB 118 PCB 99 PCB 170
Harbor porpoises
HO-PCB ND-3.8a NT NT ND-5.9b NT ND-0.3a
MeSO2-PCB NT 21.7–1176.1 7.6–618.9 NT NT NT
Fish
HO-PCBc ND NT NT ND NT ND
MeSO2-PCBd NT 0.9–1.4 1.0–2.7 NT NT NT
ND — Not Detected; NT — Not Targeted.
HO-PCBs for PCB 180 is the sum of 3-HO-PCB 180 and 4-HO-PCB 172; HO-PCBs for PCB
118 is the sum of 4-HO-PCB 120 and 3-HO-PCB 118; HO-PCBs for PCB 170 is only 4-HO-
PCB 172.
MeSO2-PCBs for PCB 101 is the sum of 3-MeSO2-PCB 101 and 4-MeSO2-PCB 101;
MeSO2-PCBs for PCB 149 is the sum of 3-MeSO2-PCB 149 and 4-MeSO2-PCB 149.
a ND in 9 out of 10 samples.
b ND in 5 out of 10 samples.
c Investigated in ﬂounder (Platichthys ﬂesus), cod (Gadus morhua), dab (Limanda
limanda), and whiting (Merlangius merlangus) caught in 2008 in the North Sea (Weijs,
unpublished data).
d Investigated in plaice (Pleuronectes platessa), sole (Solea solea), pout (Trisopterus
luscus) and whiting (Merlangius merlangus) caught in 2001 in the North Sea Covaci
(unpublished data).Netherlands, butdiedduring rehabilitation inSOSDolﬁjn,Harderwijk,
The Netherlands in 1990–2006. Levels (sum of PCBs) can be found in
Weijs et al. (2010c). Data of PCBs in blubber were used for goal 2
whereas data of PCBs in liver were not used for goal 3 since PCB
metabolites were not targeted.
Results
Of the 6 PCBs selected, only PCBs 101, 118 and 149 were involved in
all goals. Of these three PCBs, PCB 101 was randomly selected to be
shown in the manuscript (Figs. 2, 4) whereas ﬁgures of all other PCBs
can be found in Supporting Information (Fig S1–S7). PCBs 180, 99 and
170 could not be used for goal 3 becausemetabolites of those congeners
were not targeted (for PCB 99) or were only detected in low
concentrations in 1 out of 10 samples (for PCBs 180 and 170) (Table 2).
Goal 1: Models for PCBs other than PCB 153
Elimination half-lives, in the present study deﬁned as the time at
which50%of the chemical is eliminated (e.g. bymetabolic transformation,
fecal excretion) from the body, are important parameters. For most PCBs,
the literature provides several half-lives dependent on the investigated
species (e.g. humans, rodents) and circumstances (e.g. occupational
exposure, long term exposure). Initially, all models were run with the
longest elimination half-lives available in the literature (see elimination
half-lives between brackets in Table 1). However, because the curves did
not reﬂect the Black Sea dataset for 5 out of 6 PCBs, new elimination half-
lives (Table 1) were estimated by ﬁtting themodels to the Black Sea data
(i.e. model parameterization). Models for all 6 PCB congeners had two
things in common: 1) the blood/brain partition coefﬁcients (PB),
originally calculated according to Parham et al. (1997), were not
consistent with the results of the Black Sea dataset and were therefore
ﬁtted to the brain data, 2) an additional assimilation coefﬁcient for the
milk diet (AE2) was added to the models of all PCB congeners because
initial modeling attempts suggested that the models overestimated the
validationdataset fromtheBlack Sea for the youngest animalswhenusing
the same assimilation efﬁciency as the ﬁsh diet (Table 1).
Tanabe et al. (1997) reported concentrations of PCB 118, 170 and
180, but not of PCB 101, 99 and 149, in ﬁsh prey of harbor porpoises
from the Black Sea from 1993. Therefore, levels of PCB 101, 99 and 149
in the ﬁsh diet were estimated using the average concentration of the
respective congener in the milk diet (Table S1). In the PBPK model for
PCB 153 bioaccumulation in harbor porpoises, there was a 116 times
difference between the ﬁsh diet (1.1 ng/g ww; Tanabe et al., 1997)
and milk diet (127.6 ng/g ww;Weijs et al., 2010b). The factor 116 has
been used here as an estimate leading to a ﬁsh diet of 0.3 ng/g ww for
PCB 101, of 0.5 ng/g ww for PCB 99 and of 0.7 ng/g ww for PCB 149 .
PCB 101
Levels of PCB 101 in all compartments increase little with age. In
each tissue, the highest concentrations can be found for animals
younger than 1 year, especially the animals that are drinking milk or
animals that have just switched from a milk diet to a ﬁsh diet. The
elimination half-life, PB and AE2 that ﬁtted best to the dataset of the
harbor porpoises from the Black Sea are given in Table 1 and model
results can be found in Fig. 2 (A–E).
PCB 149
Because metabolic half-lives for PCB 149 are scarce in the literature,
even for typical model species such as rodents, the ﬁrst modeling
exercise used a metabolic half life of 5.7 years, similar as the metabolic
half life of PCB 101 (also group II;Wolkers et al., 1998)which resulted in
model predictions that underestimated the Black Sea dataset by far.
Therefore, the Black Sea data were used to ﬁnd a better ﬁt of the curves,
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Fig. 2. Age-dependent bioaccumulation of PCB 101 (expressed in ng/g lw) in (A) blubber, (B) liver, (C) kidney, (D) brain and (E) muscle (rest of the body) of male harbor porpoises
from the Black Sea. = Individual data from male harbor porpoises from the Black Sea from 1998 (Weijs et al., 2010a), = model prediction with tissue/blood partition
coefﬁcient calculated with the average lipid content of the respective tissue, = model predictions with tissue/blood partition coefﬁcients calculated with the minimum and
maximum lipid percentage of the respective tissue, = model prediction with ﬁtted tissue/blood partition coefﬁcient.
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(Table 1; Fig S1 A–E).
PCB 99
The longest elimination half-lives for PCB 99 in the literature are
not compatible with the Black Sea dataset for validation, so the
software was asked again to ﬁnd an elimination half-life so that the
curves would ﬁt to the Black Sea dataset, resulting in an estimated
elimination half-life of 334 years ((Table 1; Fig S2 A–E).
PCB 118
In contrast with all other PCBs in the present study, the Black Sea
data are more scattered for PCB 118 than for all other PCBs considered
so far. Nevertheless, the model, developed with the parameters from
Table 1 and a concentration of PCB 118 in the ﬁsh diet as measured by
Tanabe et al. (1997), is a fairly good reﬂection of the real life data from
the Black Sea (Fig S3 A–E).PCB 170
The curves were again underestimating the Black Sea data by far
using the elimination half-life from the literature. In contrast to PCB
99, levels of PCB 170 were measured in ﬁsh prey of harbor porpoises
from the Black Sea at a concentration of 0.18 ng/g ww (Tanabe et al.,
1997). The only parameter that can be adjusted was thus the
elimination half-life. This was again ﬁtted to the Black Sea data by
the model giving a value of 21 years (Table 1; Fig S4 A–E).
PCB 180
The concentration of PCB 180 in the ﬁsh diet from Tanabe et al.
(1997) and an elimination half-life of 9.9 years, gives slightly
increasing curves with age for all compartments, whereas they should
be increasing much more according to the Black Sea data. As for PCB
99, the model was used to ﬁnd a value for the elimination half-life so
that the curves would ﬁt better to the Black Sea dataset. Similar to PCB
99, the resulting elimination half-life was very high, namely 521 years
(Fig S5 A–E).
140 L. Weijs et al. / Toxicology and Applied Pharmacology 256 (2011) 136–145Goal 2: Assessing temporal trends for PCBs
Using the blubber data from the North Sea dataset, temporal trends
were investigated. The entire dataset (n=46) covers data from 1990
until 2008. The models used are exactly the same as developed and
parameterized in goal 1, except for the input parameters. These input
parameters, namely the concentration of the speciﬁc PCB in the ﬁsh and
milk diet, were found by Reverse Dosimetry Modeling meaning that
theywere adjusted in order toﬁnd curves thatwouldﬁt to theNorth Sea
data (Redding et al., 2008). The ratio of the concentration in milk to the
concentration in ﬁsh was kept the same as in the models that were
parameterized usingBlack Seadata (so 116 timesdifference for PCB101,
99and149;84 timesdifference for PCB118, 107 timesdifference for PCB
170 and 203 times difference for PCB 180; see Goal 1). Overall, although
the data of each year were added to the models separately, results
revealed that they could easily be divided into 2 groups, from 1990 until
2000and from2001until 2008.Within eachgroup, the levels of thePCBs
increased insigniﬁcantly in time. Between the two groups, there was a0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
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Fig. 3. Time trends in age-dependent bioaccumulation of (A) PCB 99, (B) PCB 101, (C) PCB 1
the North Sea. All concentrations are expressed in ng/g lw. = individual data for male h
harbor porpoises from the North Sea from 2001 to 2008, = model prediction for male h
from 2001 to 2008.difference between the groups with lower concentrations in the second
group (2001–2008) compared to the ﬁrst group (1990–2001). The
difference in concentrations in the diet ranged from a factor 1.9 to 3.5
with 1.9, 2.5, 2.8, 2.8, 3.3 and 3.5 for PCB 101, PCB 99, PCB 118, PCB 180,
PCB 170 and PCB 149, respectively (Fig. 3 A–F).
Goal 3: Metabolism and elimination of PCBs
Attempts were made to link the concentrations of PCB metabolites to
the models of the parent PCB congeners. This was done using data of
parent PCBs (Covaci et al., 2002), MeSO2-PCBs (Chu et al., 2003) and HO-
PCBs (Weijs, unpublished data) in liver of harbor porpoises from the
North Sea (n=10). This method was applied for PCB 101, 118 and 149,
butnot forPCB99, 170and180because themetaboliteswerenot targeted
or were present in low concentrations in only 1 out of 10 samples
(Table 2). Theoretically, under the assumption that the diet or prey (and
not seawater or air) is the only source of PCBs and/or metabolites for
marinemammals, there are three different possible situations (Letcher et0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
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18, (D) PCB 149, (E) PCB 170 and (F) PCB 180 in blubber of male harbor porpoises from
arbor porpoises from the North Sea from 1990 to 2000, = individual data for male
arbor porpoises from 1990 to 2000, = model prediction for male harbor porpoises
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not, 2) the metabolites are present in the prey, the precursor PCB is not,
and 3) the precursor PCB and its metabolites are present in the prey.
PCB 118, 101 and 149 were all present in the prey (Table 2),
making the second situation impossible. PCB 118 belongs to the ﬁrst
situation as potential HO-metabolites of PCB 118 were targeted, but
not detected in the prey (Table 2; Weijs, unpublished data). The
presence of HO-metabolites of PCB 118 is thus solely due to PCB
metabolism in the harbor porpoises. PCB 101 and 149 as well as their
MeSO2-metabolites were found in the prey, so both PCB 101 and 149
can be assigned to the third situation.
PCB 118
The difference between the model without elimination (green curve;
Fig S6) and the model with elimination (characterized by an elimination
half-life of 9.6 years) (Table 1; black curve; Fig S6) gives the concentration
of PCB 118 eliminated from the body by metabolic breakdown or fecal
excretion (gray curve; Fig S6). The levels of potential HO-metabolites of
PCB 118 are only a minor fraction of this, indicating that metabolic
breakdown isof lesser importance compared to fecal excretionof PCB118.
PCB 149
There is an increase in concentrations of metabolites of PCB 149,
similar as predicted by the model (gray curve; Fig S7). However, the
origin of the metabolites in this study, either from the prey through
bioaccumulation or from metabolic breakdown in harbor porpoises,
remains unknown.
PCB 101
Similar as PCB 149 and as predicted by themodel (gray curve; Fig. 4),
there is also an increase in concentrations of metabolites of PCB 101. For
the animals younger than 3 years, the concentrations of metabolites areFig. 4. Age-dependent elimination of PCB 101 in liver of male harbor porpoises from the
North Sea. All concentrations are expressed in ng/g lw. = individual data of PCB 101
in livers of male harbor porpoises from the North Sea, = individual data of MeSO2-
PCB metabolites of PCB 101 (Table 2), = model predictions with elimination half-
life of 6.1 years (Table 1), = model predictions without elimination, =
difference between and (thus the concentration that is eliminated), =
percentage of concentration of PCB 101-metabolites/concentration of PCB 101.situated under the gray curve, so for these animals, the origin of the
metabolites remains unknown. For the animals older than 3 years, there
is a sudden increase in concentrations of themetabolites aswell as in the
metabolites/parent compound percentages. At higher age, these animals
clearly accumulate more metabolites as can be produced through
metabolic breakdown. The difference in metabolites/parent compound
percentages between the younger animals (b3 years) and the older
animals (N3 years) suggests that the capacity formetabolic breakdownof
PCB 101 is greatly enhanced or induced at higher ages as it would be
difﬁcult to explain this steep increase simply by bioaccumulation.
Discussion
The signiﬁcance of this work is the development and demonstration
of a workable, non-invasive, computational approach to study lifetime
exposure and bioaccumulation of PCBs in protected marine mammals,
such as the harbor porpoises. For protected marine mammals,
biomonitoring data on stranded or dead animals are generally the
only experimental information available. In the past, such data were
reported as survey results in the literature and that was the end of the
study. With the application of PBPK modeling, however, the utility of
such biomonitoring results is greatly expanded to provide further
insights into the pharmacokinetics of the interested chemicals in these
marine mammals and to help with the interpretation of their toxic
effects as revealed by results of in vitro studies. This approach is certainly
in linewith the spirit of reducingor eliminating animal experimentation
advanced by REACH (Registration, Evaluation, Authorization, and
restriction of Chemical substances) in the European Union (EU).
PBPK modeling integrates computational technology and all the
physiological and biochemical information on the chemical(s) of
interest in the species of interest. Thus, it can be used as well in other
species in which in vivo experiments are often unethical, such as
humans. This report, as well as other similar work (Weijs et al., 2010a;
Weijs et al., submitted for publication), demonstrates that lifetime
modeling including special physiological states can be effectively
implemented for an entire class of chemicals. Although PBPK models
for some selected chemicals in humans already exist, only few studies
compare models for several PCBs. It is through comparisons between
highly comparable and similar compounds, such as PCBs, that the
knowledge about the kinetics of these compounds and the inﬂuence
of their biochemical properties on the kinetics can progress. This is the
ﬁrst study that compares the kinetics of several PCBs, assesses their
temporal trends and attempts to unravel metabolic pathways in a
marine mammal species through PBPK modeling. Although the use of
more datasets in the future will make the models stronger and more
robust, the datasets used now take nothing away from the quality of
the models, nor from their applications (goals 2 and 3) or conclusions.
Goal 1: Usefulness of models for other PCBs
PBPK models in the present study rely partly on biochemical
parameters found in the literature from in vitro or in vivo experiments
with other species and partly on parameters estimated by using data
of PCBs in relevant tissues of harbor porpoises from the Black Sea. In
the wild, the health condition of marine mammals ranges from
healthy to emaciated and severely ill which can inﬂuence the kinetics
of pollutants in their body as such. However, the Black Sea data used
to evaluate the models consisted of more by-caught (considered
healthy) animals than stranded (potentially sick) ones. In addition, as
the models are not entirely based on the datasets in the present study,
the model outcomes or conclusions drawn from the models are not
inﬂuenced by including data of some ill animals.
Elimination half-life
In Weijs et al. (2010b), the models with a metabolic half-life of
27.5 years for bioaccumulation of PCB 153 in male and female harbor
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was taken from a humanmodel (Verner et al., 2008) and was among the
highest for PCB 153 available in the literature. Because of the usefulness of
the human elimination half-life in the PBPK model of PCB 153 in harbor
porpoises (Weijs et al., 2010b) and the resemblance of porpoises and
humans (in body size, body weight and body composition), the same
approachwas followed in the present study. Thus, the highest elimination
half-life values from the literature were used ﬁrst, but the model was
asked to estimate new half-lives in cases where the curves initially
differed from the Black Sea data. Except for PCB 118, these new values
were slightly higher (for PCB 101) tomuch higher (for PCB 170, 149). For
PCB 180 and 99, the new half-lives even exceeded 300 years (Table 1).
Although these extremely high half-lives may seem impossible, they are
most likely an artifact caused by the relatively short life-spans of the
harbor porpoises and thus the limited number of data points that were
available in the ﬁtting-process. For animals that live longer, such as killer
whales, eliminationhalf-lives forPCB180and99wouldprobablybe lower
because of the higher number of data points at higher ages that can be
included in the ﬁtting-process. Nevertheless, for harbor porpoises that
only live for about 20 years, the elimination half-lives of PCB 180 and 99
mean that bothPCBs arebarely eliminatedduring their entire life spans. In
the present study, the elimination half-life only deals with chemicals
absorbed by the organism. Assuming that 46% (for calves that drinkmilk)
and 9% (for porpoises that eatﬁsh) of the ingested amount of PCB 180 and
45% (for calves that drinkmilk) and10% (for porpoises that eatﬁsh) of the
ingested amount of PCB 99 are not part of the model because these
percentages were not absorbed by the animals (Table 1), it is noteworthy
that it is still possible to ﬁnd PCB 180 and PCB 99 in feces of harbor
porpoises as also found in fecesofbottlenosedolphins (Marsili et al., 1995)
and right whales (Weisbrod et al., 2000).
It has been suggested that the amount of fat inﬂuences the elimination
half-life value of chemicals in an organism as the chemical is no longer
available for metabolic transformation or fecal/urinary elimination
(Grandjean et al., 2008). Compared to rodents for example, marine
mammals havemuch larger fat deposits to be able tomaintain a constant
body temperature in cold waters, to enhance locomotion and to provide
energy in the form of lipids in times of food scarcity (Koopman, 2007).
Obviously, this has a major impact on the elimination half-lives which
were found to be much higher than those reported in the literature for
humans or rodents. Elimination half-lives in the literature are often
calculated after experiments in which the organisms were exposed to
high doses of pollutants for only a short term (e.g. Lee et al., 2002;
MaruyamaandAoki, 2006;Reitz et al., 1988).However, informationabout
elimination half-lives after continuous exposure for years is scarce.
Collectively, therefore, larger fat reserves and lifetime exposure, may lead
to half-lives that are expected to be much higher as found in exposure
experiments in the literature.
In themodels, changes in the input (concentration of the compound
in ﬁsh or milk) or elimination half-life can give the same model results.
Concentrations of all PCBs were measured in seven milk samples from
animals from the Black Sea and concentrations of PCB 118, PCB 170 and
PCB 180 in their prey were taken from Tanabe et al. (1997), both of
which were reliable sources for intake levels of the respective PCB
congeners. For PCB 118, 170 and 180, the only appropriate parameter to
adjust in the models is thus the elimination half-life.
For PCB 99, 101 and 149, the levels in the ﬁsh prey were not
available in Tanabe et al. (1997), so these levels were estimated. Since
milk concentrations were available for all PCBs, there were actually
two different ways to estimate the ﬁsh levels for PCB 99, 101 and 149:
1) The ﬁrst way was to use the milk-to-ﬁsh ratio of PCB 153 (Weijs et
al., 2010b), PCB 118, 170 or 180 and the milk levels of PCB 99, 101
and 149;
2) The second way was to look at the PCB patterns in ﬁsh in general
and the ﬁsh data that we have for PCB 153, 118, 170 and 180 from
Tanabe et al. (1997), e.g. the proportion of PCB 149 to PCB 153 inNorth Sea ﬁsh is probably the same in Black Sea ﬁsh (and the levels
of PCB 153 in Black Sea ﬁsh can be found in Tanabe et al., 1997).
In the present study, both ways were used: the ﬁrst way was used
to estimate the ﬁsh levels and the second way to check whether these
ﬁsh levels were realistic. The following discussion provides more
speciﬁcs to the estimations of the ﬁsh levels of PCB 99, 101 and 149. In
the PCB 153 model (Weijs et al., 2010b), there is a 116 times
difference between the PCB 153 concentration in ﬁsh and milk which
was used to estimate the levels in ﬁsh of PCB 99, 101 and 149. This
factor differs little from the 84, 107 and 203 times differences between
the concentration of PCB 118, 170 and 180, respectively, in ﬁsh and
milk in the current PCB 118, 170 and 180 models. To test whether the
calculated ﬁsh levels of PCB 99, 101 and 149 were comparable with
real concentrations in ﬁsh, the patterns of PCBs reported in ﬁsh were
taken into account as well. In the North Sea, levels of PCB 149 in
several ﬁsh species may reach relatively high concentrations which
are between 30 and 50% of the levels of PCB 153 (Voorspoels et al.,
2004). The concentration used in the present study for PCB 149, which
is 0.7 ng/g ww or 64% of 1.1 ng/g ww (input used in the PCB 153
model (Weijs et al., 2010b), seems therefore already high enough.
Consequently, an increase in elimination half-life in the PCB 149
model was assumed to be more logic than an increase in dietary input
of ﬁsh. Similar, in ﬁsh species from the North Sea, PCB 99 is between
24 and 35% of the concentration of PCB 153 (Voorspoels et al., 2004).
This would give a concentration of PCB 99 between 0.26 and 0.39 ng/g
ww. Therefore, the value of 0.51 ng/g ww, calculated as a 116 times
difference compared to the value in milk, is already high enough and
should not be any higher just to get a steep increase in the curves. So
also for PCB 99, a higher elimination half-life is preferred rather than
an increase in input concentration. In the present study, concentra-
tions in ﬁsh were used as a constant thereby probably neglecting a
potential decrease in ﬁsh levels over time. Tanabe et al. (1997) report
on PCBs in harbor porpoises and their prey (European anchovy and
whiting) in the Black Sea from 1993. Since there are no available prey
or ﬁsh data for harbor porpoises in the current dataset from 1998, the
ﬁsh data from 1993 were used for further calculations. To our
knowledge, there are no reports of gradual decreases in ﬁsh
concentrations from the Black Sea. However, as concentrations of
PCBs in ﬁsh probably change over time, it is worthwhile to mention
that future models would beneﬁt from having ﬁsh data reﬂecting
these changes.
Blood/brain partition coefﬁcients
Tissue/blood partition coefﬁcients were calculated with the
method of Parham et al. (1997). This method is based on the lipid
percentage of the respective tissues (Weijs et al., 2010a) which is the
most logical background for the partitioning of lipophilic compounds.
All calculated tissue/blood partition coefﬁcients worked nicely for all
PCBs, except for the blood/brain partition coefﬁcients. Unlike the
blood–brain barriers (BBB) in ﬁsh, mammalian BBBs have been
suggested to act as a potential protective shield by blocking some
chemicals from entering the brain. Bachour et al. (1998) found a
uniformly distribution of PCBs in several tissues, including the brain,
of ﬁsh (rainbow trout), whereas there were signiﬁcantly lower
concentrations of PCBs in the brain of mammals (fox, human)
compared to all other tissues investigated. However, next to the
presence of a BBB, there is also the possibility that the lipid
composition of the brain affects the accumulation of PCBs. The brain
is mainly made up of polar phospholipids and sphingolipids whereas
it has only a minor portion of triglycerides in contrast with other
tissues. In an exposure experiment with chicken embryos, Maervoet
et al. (2005) found that concentrations of PCBs (PCB 77, 153 and 180)
remained relatively stable in the brain at the latest stage before
hatching, while the levels increased exponentially in other tissues
such as the liver. Considering that the BBB was still incomplete at that
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concluded that the speciﬁc lipid composition of the brain is less
attractive for lipophilic compounds such as PCBs and thus responsible
for the lower concentrations of PCBs found in the brain. In vitro studies
have also proven that PCBs have a much higher afﬁnity for triglycerides
than for phospholipids which is indicative for a lesser bioaccumulation
in the brain (Sandermann, 2003).
Therefore, a different lipid composition might indeed be the
reason why concentrations of PCBs are lower in the brain than in any
other tissue. However, it is probably not the only explanation. The
lipid composition of the brain of ﬁsh (Atlantic herring) is comparable
to the lipid composition of the brain of mammals with a higher
proportion of polar lipids in mature animals (Mourente and Tocher,
1992). Together with the results of Bachour et al. (1998), this would
mean that there is indeed something like a BBB that results in lower
concentrations in the brain of mammals compared to other tissues. In
the present study, lipids were determined gravimetrically and a
hexane/acetone mixture was used for extraction (Weijs et al., 2010a).
This method allows to measure triglycerides, cholesterol and less
polar phospholipids, but not polar phospholipids or sphingolipids. The
lipid percentages were then used to calculate the blood/tissue
partition coefﬁcients (Parham et al., 1997) which were for the
blood/brain partition coefﬁcients, in all models, too high compared to
the Black Sea dataset.
The adjusted (ﬁtted) blood/brain partition coefﬁcients are, for all
PCB congeners, 2.5 to 3 times lower than the partition coefﬁcients
originally calculated with themethod of Parham et al. (1997). The fact
that this is independent of the molecular sizes of the molecules (PCB
99 has a comparable blood/brain partition coefﬁcient as PCB 180), is in
favor of the theory that the lipid composition of the brain determines
the accumulation of PCBs in the brain. This is also supported by the
lower concentrations of the PCBs found in the brain of the fetus
compared to blubber, liver or kidney (Table 1). In humans, the BBB is
incompletely developed at birth (Anthony et al., 1996). If this is true
formarinemammals as well, than the lower PCB concentrations in the
brain of the fetus can only be caused by the different lipid
composition. However, the inﬂuence of the BBB cannot be ruled out
as there are studies that have reported that the BBB excludes
effectively substances with molecular weights greater than 180 Da
(Doolittle et al., 1998), while molecular weights of penta-PCBs (such
as PCB 99) and hepta-PCBs (such as PCB 180) are between 325 and
400 Da. Lower concentrations of PCBs in the brains of pilot whales and
harbor porpoises compared to levels in other tissues were also
reported by Tilbury et al. (1999) and Tilbury et al. (1997).
Assimilation efﬁciency for calves
Debier et al. (2003) and Beckmen et al. (1999) reported that there
is a selective gastrointestinal uptake of PCBs from milk, but
assimilation efﬁciencies for individual PCBs from milk remained
unknown. Hickie et al. (1999) used higher assimilation efﬁciency
from milk than from ﬁsh in the models of beluga whales, but did not
discuss PCBs separately. In the present study, the model outputs for
the youngest animals overestimated the dataset used for validation
when using identical assimilation efﬁciencies as for the ﬁsh. There
are basically two parameters that can inﬂuence the input of PCBs
through milk, namely the assimilation efﬁciency for milk and the
concentration of the PCB in the milk. The concentrations of the
individual PCBs in milk were analyzed in 7 milk samples. The only
parameter that could be changedwas thus the assimilation efﬁciency
from the milk. The resulting assimilation efﬁciencies for the milk
range from almost 50 to 70%, which differs from to the assimilation
efﬁciencies for the ﬁsh (90–99%). As unabsorbed PCBs would end up
in the feces, concentrations of PCBs in feces of calves should be
higher relative to PCBs in feces of older animals. However, fecal
samples of harbor porpoises were not available, so this explanation
could not be checked.Goal 2: Assessing temporal trends for parent PCBs
Concentrations of all PCBs investigated in harbor porpoises from
the North Sea decreased over a time period of 18 years (1990–2008)
although not at the same rate (Fig. 3 A–F). Considering the levels of
the PCB congeners in liver of harbor porpoises of 5 years of age for
example, levels of PCB 149 decreased the fastest (from 6675 ng/g lw
in 1990–2000 to 1943 ng/g lw in 2001–2008; Fig. 3D) whereas levels
of PCB 101 decreased the slowest (from 561 ng/g lw in 1990–2000 to
309 ng/g lw in 2001–2008; Fig. 3B). This decrease in PCB levels in
harbor porpoises over time is most likely due to a decline in PCBs in
the ﬁsh, thus a decline in input concentrations for the porpoises over
time. In Europe, declining PCB levels over time were reported in
several ﬁsh species (Skåre et al., 1985; Szlinder-Richert et al., 2009).
Decreasing levels over time were also reported for several marine
mammal species (harbor porpoises-Law et al., 2010; beluga whales-
Lebeuf et al., 2007; Baikal and Caspian seals-Tanabe et al., 2003; polar
bears-Dietz et al., 2004) although there were also reports about
increasing PCB concentrations over time (sea lions-Borrell et al., 2010;
northern fur seals-Kajiwara et al., 2004). Despite these decreasing PCB
trends in the North Sea, the area is still a highly polluted area for
several years to come.
Goal 3: Metabolism/elimination
Metabolic breakdown and/or elimination pathways are typically
difﬁcult to study in living marine mammals, however, in vitro studies
in these animals exist. In an in vitro hepatic microsomal assay with
cells from beluga whales, McKinney et al. (2006) found a slow, but
signiﬁcant metabolic biotransformation of PCB 118 (98±1% remain-
ing), whereas PCB 101 and PCB 105 were not depleted. For PCB 118,
the depletion of 2% is roughly 10 times higher than the ratio between
PCB 118 metabolites and the parent compound which ranged from
0 to 0.26% (Fig S6) in the present study. This discrepancymight be due
to the duration of exposure; the assay was only 90 min whereas
animals in the wild are continuously exposed. PCB 118 is a molecule
without vicinalmeta, para H-atoms, and is as such metabolized by the
cytochrome P450 monooxygenase isoform CYP1A, which is present in
marine mammals (Hirakawa et al., 2007; Miller et al., 2005; Routti et
al., 2008; Tilley et al., 2002; Wilson et al., 2010). Yordy et al. (2010)
found that concentrations of PCBs relying on CYP1A metabolism did
not increase with age in bottlenose dolphins, thus assuming a
metabolic pathway for these congeners in cetaceans. In the present
study, HO-metabolites of PCB 118 were detected in 2 out of 6 young
animals (age b3 years) and in 3 out of 4 older animals (age N3 years).
This might be an indication for an age-dependent induction of the
CYP1A system although this needs further investigation with a higher
sample size.
In contrast to what was found by McKinney et al. (2006), PCB 101
is probably metabolized in liver of harbor porpoises as has been
reported for gray seals (Li et al., 2003). PCB 101 has vicinalmeta, para
H-atoms, 2 Cl-atoms at both ortho-positions and is metabolized by
CYP2B and 3A family enzymes which are present in marine mammals
(Li et al., 2003; Routti et al., 2008). On the other hand, metabolites of
this compound have been found in the prey of the harbor porpoises as
well (Table 2). According to the PCB 101 model in the present study
and the PCB 101-metabolites detected in the harbor porpoises, the
animals, especially at older ages, havemore PCB 101-metabolites than
they can produce through metabolic breakdown (Fig. 4). It is also
apparent that the levels of the PCB 101-metabolites are much higher
for older animals (N3 years) than for younger animals (b3 years).
Dietary accumulation of PCB 101-metabolites should be a continuous
process shown as a gradual increase in metabolite levels. Fig. 4,
however, shows a more sudden increase in metabolites for older
animals compared to younger animals suggesting that there might be
an age-dependent biotransformation of PCB 101 additional to a
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with age.
The increase in levels of PCB 149 metabolites is more gradual or
continuous (Fig S7) than for the PCB 101 metabolites (Fig. 4). In the
past, PCB 149 has not been the focus of many studies as it is not very
common in marine mammals other than cetaceans. In harbor
porpoises from the North Sea, PCB 149 is consistently measured as
the third congener after PCBs 153 and 138 (Weijs et al., 2009a). In
other cetacean species, PCB 149 is also considered as one of the most
persistent PCB congeners. In theory, PCB 149 is metabolized by
CYP2B/3A enzyme systems, but that probably does not play an
important role taken the persistence of PCB 149 in cetaceans into
account. Yordy et al. (2010) found a signiﬁcant relationship between
the age of bottlenose dolphins and the concentration of PCBs
subjected to CYP2B/3A enzymes. In the present study, the continuous
increase in PCB 149-metabolites (Fig S7) can be explained by dietary
bioaccumulation, although possible metabolic biotransformation of
PCB 149 cannot be completely excluded based on the PCB 149 model
alone.Conclusions
Understanding the bioaccumulation of pollutants and associated
risks in marine mammals is a challenging problem. In silico or
computer-based models take the animal as a whole, but often lack
important, detailed information about distribution or uptake process-
es. This information can be taken from studies with other organisms
such as rodents, but that does not always seem to work because of the
physiological differences between marine mammals and rodents. In
the present study, the estimated elimination half-lives of PCBs in
marine mammals were higher to much higher compared to the
elimination half-lives of PCBs taken from the literature, probably
because of the greater lipid deposits in marine mammals. For the
brain, not only the lipid percentage plays an important role in the
distribution of chemicals, also the lipid composition, together with a
potential inﬂuence of the blood–brain barrier, are determining factors
for the bioaccumulation of lipophilic contaminants. Although more
physiological background information of marine mammals (e.g. lipid
composition of the tissues, enzyme-mediated metabolic transforma-
tion) would enhance the extrapolation of the models from one
chemical to the other, PBPK models are certainly useful. Once they
have been developed, these models can be used for a broad range of
applications, such as visualizing temporal trends or shedding some
light on possible metabolic breakdown capacities and as such, they go
further than simply describing the results of typical biomonitoring
studies. As developed and used in the present study, PBPK models are
non-invasive and non-destructive which is the only possible approach
to study the kinetics of chemicals in marine mammals.Conﬂict of interest statement
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